These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 16611021)
41. In vitro metabolic profiling of synthetic cannabinoids by pooled human liver microsomes, cytochrome P450 isoenzymes, and Cunninghamella elegans and their detection in urine samples. Gaunitz F; Dahm P; Mogler L; Thomas A; Thevis M; Mercer-Chalmers-Bender K Anal Bioanal Chem; 2019 Jun; 411(16):3561-3579. PubMed ID: 31183523 [TBL] [Abstract][Full Text] [Related]
42. CYP3A4 expressed by insect cells infected with a recombinant baculovirus containing both CYP3A4 and human NADPH-cytochrome P450 reductase is catalytically similar to human liver microsomal CYP3A4. Lee CA; Kadwell SH; Kost TA; Serabjit-Singh CJ Arch Biochem Biophys; 1995 May; 319(1):157-67. PubMed ID: 7771780 [TBL] [Abstract][Full Text] [Related]
44. In vitro metabolism of a new neuroprotective agent, KR-31543 in the human liver microsomes: identification of human cytochrome P450. Ji HY; Lee SS; Yoo SE; Kim H; Lee DH; Lim H; Lee HS Arch Pharm Res; 2004 Feb; 27(2):239-45. PubMed ID: 15022728 [TBL] [Abstract][Full Text] [Related]
45. Inhibition of cyclosporine and tetrahydrocannabinol metabolism by cannabidiol in mouse and human microsomes. Jaeger W; Benet LZ; Bornheim LM Xenobiotica; 1996 Mar; 26(3):275-84. PubMed ID: 8730919 [TBL] [Abstract][Full Text] [Related]
46. In vitro evaluation of the disposition of A novel cysteine protease inhibitor. Jacobsen W; Christians U; Benet LZ Drug Metab Dispos; 2000 Nov; 28(11):1343-51. PubMed ID: 11038163 [TBL] [Abstract][Full Text] [Related]
47. Metabolism of 2,5-bis(trifluoromethyl)-7-benzyloxy-4-trifluoromethylcoumarin by human hepatic CYP isoforms: evidence for selectivity towards CYP3A4. Renwick AB; Lewis DF; Fulford S; Surry D; Williams B; Worboys PD; Cai X; Wang RW; Price RJ; Lake BG; Evans DC Xenobiotica; 2001 Apr; 31(4):187-204. PubMed ID: 11465405 [TBL] [Abstract][Full Text] [Related]
48. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of ethosuximide by human hepatic microsomal enzymes. Bachmann K; He Y; Sarver JG; Peng N Xenobiotica; 2003 Mar; 33(3):265-76. PubMed ID: 12637244 [TBL] [Abstract][Full Text] [Related]
49. Cytochrome P450 3A-dependent metabolism of a potent and selective gamma-aminobutyric acid Aalpha2/3 receptor agonist in vitro: involvement of cytochrome P450 3A5 displaying biphasic kinetics. Ma B; Polsky-Fisher SL; Vickers S; Cui D; Rodrigues AD Drug Metab Dispos; 2007 Aug; 35(8):1301-7. PubMed ID: 17460031 [TBL] [Abstract][Full Text] [Related]
50. Glucuronidation of mycophenolic acid by Wistar and Mrp2-deficient TR- rat liver microsomes. Westley IS; Morris RG; Evans AM; Sallustio BC Drug Metab Dispos; 2008 Jan; 36(1):46-50. PubMed ID: 17908922 [TBL] [Abstract][Full Text] [Related]
51. Kinetics of testosterone 6beta-hydroxylation in the reconstituted system with similar ratios of purified CYP3A4, NADPH-cytochrome p450 oxidoreductase and cytochrome B5 to human liver microsomes. Taguchi M; Imaoka S; Yoshii K; Kobayashi K; Hosokawa M; Shimada N; Funae Y; Chiba K Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):53-63. PubMed ID: 11458985 [TBL] [Abstract][Full Text] [Related]
52. Cyclosporin metabolism by human gastrointestinal mucosal microsomes. Webber IR; Peters WH; Back DJ Br J Clin Pharmacol; 1992 Jun; 33(6):661-4. PubMed ID: 1389941 [TBL] [Abstract][Full Text] [Related]
53. In vitro metabolism of simvastatin in humans [SBT]identification of metabolizing enzymes and effect of the drug on hepatic P450s. Prueksaritanont T; Gorham LM; Ma B; Liu L; Yu X; Zhao JJ; Slaughter DE; Arison BH; Vyas KP Drug Metab Dispos; 1997 Oct; 25(10):1191-9. PubMed ID: 9321523 [TBL] [Abstract][Full Text] [Related]
54. Characterization of benidipine and its enantiomers' metabolism by human liver cytochrome P450 enzymes. Yoon YJ; Kim KB; Kim H; Seo KA; Kim HS; Cha IJ; Kim EY; Liu KH; Shin JG Drug Metab Dispos; 2007 Sep; 35(9):1518-24. PubMed ID: 17537876 [TBL] [Abstract][Full Text] [Related]
55. Role of CYP3A4 and CYP2C19 in the stereoselective metabolism of lansoprazole by human liver microsomes. Katsuki H; Hamada A; Nakamura C; Arimori K; Nakano M Eur J Clin Pharmacol; 2001 Dec; 57(10):709-15. PubMed ID: 11829200 [TBL] [Abstract][Full Text] [Related]
56. Biotransformation of phenol to hydroquinone and catechol by rat liver microsomes. Sawahata T; Neal RA Mol Pharmacol; 1983 Mar; 23(2):453-60. PubMed ID: 6835203 [TBL] [Abstract][Full Text] [Related]
57. Territrems B and C metabolism in human liver microsomes: major role of CYP3A4 and CYP3A5. Peng FC; Chang CC; Yang CY; Edwards RJ; Doehmer J Toxicology; 2006 Feb; 218(2-3):172-85. PubMed ID: 16337070 [TBL] [Abstract][Full Text] [Related]
58. Mechanism of chloroform nephrotoxicity. III. Renal and hepatic microsomal metabolism of chloroform in mice. Smith JH; Hook JB Toxicol Appl Pharmacol; 1984 May; 73(3):511-24. PubMed ID: 6719466 [TBL] [Abstract][Full Text] [Related]
59. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Feierman DE; Lasker JM Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601 [TBL] [Abstract][Full Text] [Related]
60. Determination of a quantitative relationship between hepatic CYP3A5*1/*3 and CYP3A4 expression for use in the prediction of metabolic clearance in virtual populations. Barter ZE; Perrett HF; Yeo KR; Allorge D; Lennard MS; Rostami-Hodjegan A Biopharm Drug Dispos; 2010 Nov; 31(8-9):516-32. PubMed ID: 21104927 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]